[吸烟对晚期肺癌免疫疗法的疗效的影响]
F Biney1, É Giroux-Leprieur2, C Daniel3
1Service de pneumologie, CHSF, Corbeil Essonne, France.
Revue des maladies respiratoires
|May 15, 2025
概括
吸烟状态并没有显著影响晚期非小细胞肺癌 (NSCLC) 患者的免疫疗法的有效性. 建议对较大群体进行进一步的研究,以确认这些发现用于肺癌治疗.
科学领域:
- 在瘤学瘤学.
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺癌仍然是全球主要的死亡原因之一.
- 虽然免疫治疗改善了转移性肺癌的存活率,但其疗效可能受到吸烟状况的影响.
- 这项研究调查了基于吸烟史的高级非小细胞肺癌 (NSCLC) 免疫疗法的有效性.
研究的目的:
- 评估一线免疫治疗在晚期非小细胞肺癌 (NSCLC) 中的有效性.
- 为了确定患者的吸烟状态是否会影响免疫疗法治疗的结果.
- 分析与吸烟史有关的整体存活率 (OS) 和无进展存活率 (PFS).
主要方法:
- 从2018年1月到2019年,对105名IV期NSCLC患者进行了回顾性分析,这些患者接受了第一线免疫疗法 (单独或组合) 治疗.
- 数据来自法国伊尔德法国的三个中心收集.
- 主要终点:整体存活率 (OS);次要终点:无进展存活率 (PFS),按吸烟状况分层 (吸烟者,前吸烟者,非吸烟者).
主要成果:
- 该研究包括105名患者:38%是活跃吸烟者,9.5%是非吸烟者,65.7%患有腺癌.
- 平均生存期为17个月 (吸烟者),23.2个月 (前吸烟者) 和24.9个月 (非吸烟者).
- 平均PFS为4.9个月 (吸烟者),7.6个月 (前吸烟者) 和4个月 (非吸烟者),在各组中没有观察到统计学上显著的差异.
结论:
- 吸烟状态似乎没有显著改变免疫疗法的有效性,在这个队列的晚期NSCLC患者.
- 这些发现表明,免疫疗法可以有效,无论患者的吸烟史.
- 需要进行更大规模的研究来验证这些结果,并进一步阐明吸烟状态在免疫治疗反应中的作用.
相关概念视频
Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Pulmonary Tuberculosis I
210
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
210
Statistical Methods for Analyzing Epidemiological Data
250
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
250


